Fisher Naomi D L, Fera Liliana E, Dunning Jacqueline R, Desai Sonali, Matta Lina, Liquori Victoria, Pagliaro Jaclyn, Pabo Erika, Merriam Mary, MacRae Calum A, Scirica Benjamin M
Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts.
Clin Cardiol. 2019 Feb;42(2):285-291. doi: 10.1002/clc.23141. Epub 2019 Jan 17.
Hypertension remains poorly controlled on the population level. National rates of control, even when defined leniently by BP < 140/90 mm Hg, are only ~50%. As growing healthcare costs coincide with tighter blood pressure (BP) targets, innovative management programs are needed to maximize efficiency of care delivery and optimize control.
We aimed to develop a remote, navigator-led hypertension innovation program that would leverage algorithmic care pathways, home BP measurements and patient coaching to allow rapid and complete medication titration.
A multidisciplinary group of clinical experts from subspecialties and primary care collaborated to develop an evidence-based clinical algorithm, designed to be automated and administered by non-licensed patient navigators. In the development stage, a prospective pilot cohort of 130 patients was managed by nurse practitioners and pharmacists to ensure efficacy and safety. Patients with clinic BP ≥ 140/90 mm Hg were enrolled and given a Bluetooth-enabled BP device. Home BPs were transmitted automatically into the electronic medical record. Medication titrations were performed by phone at biweekly intervals, based upon weekly average BP, until home BP was controlled at <135/85 mm Hg.
Eighty-one percent of all enrolled, and 91% of those patients who regularly measured home BP achieved goal, in an average of 7 weeks. Control was reached similarly across races, genders, and ages.
A home-based BP control program run by non-physicians can provide efficient, effective and rapid control, suggesting an innovative paradigm for hypertension management. This program is effective, sustainable, adaptable, and scalable to fit current and emerging national systems of healthcare.
高血压在人群层面的控制情况仍然很差。即使将血压控制标准宽松地定义为收缩压<140/舒张压<90 mmHg,全国的控制率也仅约为50%。随着医疗成本的不断增加与血压控制目标的日益严格,需要创新的管理方案来提高护理效率并优化控制效果。
我们旨在开发一个由导航员主导的远程高血压创新项目,该项目将利用算法护理路径、家庭血压测量和患者指导,以实现快速且完全的药物滴定。
来自各亚专业和初级保健领域的多学科临床专家团队合作开发了一种基于证据的临床算法,该算法旨在由无执照的患者导航员进行自动化管理。在开发阶段,由执业护士和药剂师管理一个130名患者的前瞻性试点队列,以确保疗效和安全性。入选患者的诊室血压≥140/90 mmHg,并配备了支持蓝牙的血压设备。家庭血压数据会自动传输到电子病历中。根据每周平均血压,每两周通过电话进行一次药物滴定,直到家庭血压控制在<135/85 mmHg。
所有入选患者中有81%,以及那些定期测量家庭血压的患者中有91%在平均7周内达到了目标血压。不同种族、性别和年龄的患者血压控制情况相似。
由非医生运行的家庭血压控制项目可以提供高效、有效且快速的血压控制,这为高血压管理提出了一种创新模式。该项目有效、可持续、适应性强且可扩展,以适应现有的和新兴的国家医疗体系。